The authors report dose-response relationships for atropine in their rat model of human delirium. In this model, anticholinergic mechanisms are an important cause and may be a neurochemical final common pathway for diverse etiologies of delirium. Four intravenous (i.v.) bolus doses of atropine (27.5, 13.5, 6.875, and 3.44 mg/kg) were studied along with the originally reported dose of 55 mg/kg and saline control. Subsequent iv infusions were also proportionately reduced. EEG frequency and amplitude, maze performance, and subjective behavioral descriptions were taken over 320-minute study periods. Repeated-measures analysis of variance compared data between groups, and effect sizes were calculated. Dosages to be used in future studies are discussed.
No takes yet. Share an insight, caveat, or question.
Leavitt et al. (1994) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: